EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group

Norbert Galldiks iD, Timothy J Kaufmann, Philipp Vollmuth, Philipp Lohmann iD, Marion Smits iD, Michael C Veronesi, Karl-Josef Langen, Roberta Rudà, Nathalie L Albert, Elke Hattingen, Ian Law, Markus Hutterer und 5 weitere

Neuro-Oncology · 05.07.2024 · 26 (7) · 1181-1194

DOI: 10.1093/neuonc/noae049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 11.03.2024. Verfasst von Norbert Galldiks und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Brain Neoplasms, Positron-Emission Tomography, Magnetic Resonance Imaging. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain tumor diagnostics have significantly evolved with the use of positron emission tomography (PET) and advanced magnetic resonance imaging (MRI) techniques. In addition to anatomical MRI, these modalities may provide valuable information for several clinical applications such as differential diagnosis, delineation of tumor extent, prognostication, differentiation between tumor relapse and treatment-related changes, and the evaluation of response to anticancer therapy. In particular, joint recommendations of the Response Assessment in Neuro-Oncology (RANO) Group, the European Association of Neuro-oncology, and major European and American Nuclear Medicine societies highlighted that the additional clinical value of radiolabeled amino acids compared to anatomical MRI alone is outstanding and that its widespread clinical use should be supported. For advanced MRI and its steadily increasing use in clinical practice, the Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Development Coalition provided more recently an updated acquisition protocol for the widely used dynamic susceptibility contrast perfusion MRI. Besides amino acid PET and perfusion MRI, other PET tracers and advanced MRI techniques (e.g. MR spectroscopy) are of considerable clinical interest and are increasingly integrated into everyday clinical practice. Nevertheless, these modalities have shortcomings which should be considered in clinical routine. This comprehensive review provides an overview of potential challenges, limitations, and pitfalls associated with PET imaging and advanced MRI techniques in patients with gliomas or brain metastases. Despite these issues, PET imaging and advanced MRI techniques continue to play an indispensable role in brain tumor management. Acknowledging and mitigating these challenges through interdisciplinary collaboration, standardized protocols, and continuous innovation will further enhance the utility of these modalities in guiding optimal patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsPositron-Emission TomographyMagnetic Resonance ImagingHumans

Stichwörter der Autor:innen

CESTMR spectroscopyamino acid PETdiffusion-weighted imagingperfusion-weighted imaging

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Institute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.
  • Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Norbert Galldiks, Philipp Lohmann, Marion Smits, Riccardo Soffietti, Michael Weller

Zitieren

APA

Galldiks, N., Kaufmann, T. J., Vollmuth, P., Lohmann, P., Smits, M., Veronesi, M. C., Langen, K. J., Rudà, R., Albert, N. L., Hattingen, E., Law, I., Hutterer, M., Soffietti, R., Vogelbaum, M. A., Wen, P. Y., Weller, M., & Tonn, J. C. (2024). Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group. Neuro-Oncology, 26(7), 1181-1194. https://doi.org/10.1093/neuonc/noae049

Vancouver

Galldiks N, Kaufmann TJ, Vollmuth P, Lohmann P, Smits M, Veronesi MC, et al. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group. Neuro-Oncology. 2024;26(7):1181-1194. doi:10.1093/neuonc/noae049

BibTeX
@article{Galldiks2024,
  author = {Galldiks, Norbert and Kaufmann, Timothy J and Vollmuth, Philipp and Lohmann, Philipp and Smits, Marion and Veronesi, Michael C and Langen, Karl-Josef and Rudà, Roberta and Albert, Nathalie L and Hattingen, Elke and Law, Ian and Hutterer, Markus and Soffietti, Riccardo and Vogelbaum, Michael A and Wen, Patrick Y and Weller, Michael and Tonn, Joerg-Christian},
  title = {Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {7},
  pages = {1181--1194},
  doi = {10.1093/neuonc/noae049}
}
Kostenlos starten →